Summary Information:
Regulus Therapeutics Inc. Common Stock
NASDAQ:RGLS


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Regulus Therapeutics Inc. Common Stock
Exchange: NASDAQ
Symbol: RGLS
SEC CIK: 0001505512
Phone: 858-202-6300
4224 CAMPUS POINT COURT
SUITE 210
SAN DIEGO CA 92121
CEO: Joseph Hagan
Price when page updated: 1.33 Date: 2023-12-01
Company Website:
regulusrx.com

_Description: Regulus Therapeutics Inc. is a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a pipeline complemented by a rich intellectual property estate in the microRNA field. Regulus maintains its corporate headquarters in La Jolla, CA.

IPO YEAR:
2012
Sector:
Health Care
Industry:
Biotechnology: Pharmaceutical Preparations
ADRTSO:

MarketCap:
26896154.00
Beta:
1.123951122134486
52 Week High:
2.32
52 Week Low:
0.318
52 Week Change:
-0.7308333333333333
Short Interest:

Short Date:

Shares Outstanding:
87047832
Dividend Rate:
0
Dividend Yield:
N/A
ExDividend Date:

Latest EPS:

Latest EPS Date:
9 Nov 2022
Float:
0
return on Equity:
10.50%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
N/A
ttmEPS:
0
Revenue:
$0.00
Gross Profit:

Cash:

Debt:

Institution Percent:
81.40%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
0.30%
Return on Assets:
9.80%
Return on Capital:

Profit Margin:
42.20%
Price to Sales:
9.07
Price To Book:
2.23
Short Ratio:
4.07
PE Ratio:
0
Employees:
24
1Y Guesstimate
9.091:5.0:4




__The following are links to various summary and news pages for
__Regulus Therapeutics Inc. Common Stock [ RGLS ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-12-01